Switching from Zepbound to Wegovy
The short answer
For switching from Zepbound to Wegovy, no label converts a Zepbound dose to a Wegovy dose. The Wegovy label states a starting dose of 0.25 mg once weekly for the injection, raised every 4 weeks to 2.4 mg, or 1.5 mg once daily for the tablets. Self-pay Wegovy pens cost $349 a month at 1 mg to 2.4 mg. Your prescriber decides where you start.
Key takeaways
- No label turns a Zepbound dose, such as 7.5 mg or 10 mg, into a Wegovy dose.
- Wegovy's injection schedule is a 16-week climb to 2.4 mg. Ask your prescriber whether you follow all of it.
- Wegovy also comes as a daily pill. The label gives no steps for reaching it from Zepbound.
- Zepbound covered for sleep apnea? Wegovy isn't approved for it, so check with your plan before switching.
- Paying cash through NovoCare? Wegovy pens from 1 mg to 2.4 mg are $349 a month, with no refill window.
What the labels say about switching from Zepbound to Wegovy
The Wegovy label gives one starting dose for everyone: 0.25 mg once weekly. It gives no dose conversion from Zepbound.
The recommended starting dosage of WEGOVY injection is 0.25 mg administered subcutaneously once weekly.
The Wegovy label says using Wegovy tablets or Wegovy injection together with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.
FDA label: Revised: 6/2026 (DailyMed version 19)
The Zepbound label says using Zepbound together with other tirzepatide-containing products or with any GLP-1 receptor agonist is not recommended.
ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.
FDA label: Revised: 8/2026 (DailyMed version 40)
Try other combinations in the switching planner. Switching is a prescriber decision.
Some people move from Zepbound to Wegovy because a plan changes its preferred brand, because of price, or because a prescriber wants to try semaglutide. Zepbound contains tirzepatide and Wegovy contains semaglutide, so your dose doesn’t carry across.
What both labels say
The Wegovy label has a section on switching, but it only covers Wegovy injection and Wegovy tablets. It gives no way in from Zepbound. The Zepbound label doesn’t discuss leaving for another medicine.
Each label does have a limitation of use. Wegovy’s says using it with any other GLP-1 receptor agonist isn’t recommended. Zepbound’s says using it with any GLP-1 receptor agonist isn’t recommended. Ask your prescriber when your last Zepbound dose and your first Wegovy dose should fall, because no label gives the gap.
The Wegovy schedule in its label
Injection. The recommended starting dose is 0.25 mg once weekly. The dose table then runs 0.5 mg for weeks 5 through 8, 1 mg for weeks 9 through 12, and 1.7 mg for weeks 13 through 16. The usual maintenance dose (the dose you stay on) is 2.4 mg from week 17. The label says that if a dose isn’t tolerated, waiting 4 weeks before the next increase can be considered. Adults who tolerate 2.4 mg for at least 4 weeks and need more weight reduction may go up to 7.2 mg.
Tablets. Wegovy also comes as a once-daily pill, which Zepbound doesn’t. The tablets start at 1.5 mg and reach the 25 mg maintenance dose from day 91.
As written, the injection schedule is a 16-week climb. The label doesn’t say whether someone coming from tirzepatide follows all of it, whether they were on 7.5 mg or 15 mg of Zepbound. Ask your prescriber that question directly.
Day-to-day differences
You inject Wegovy on the same day each week, at any time of day, with or without meals, in the abdomen, thigh or upper arm. Single-dose pens are stored in the refrigerator. Before the cap comes off, they can be kept at room temperature up to 86°F for up to 28 days. If you used Zepbound vials with a syringe, the Wegovy single-dose pen removes that step.
Price before and after
If you pay cash:
- Zepbound vials or KwikPen through LillyDirect: $399 a month at 5 mg, and $449 at 7.5 mg to 15 mg if you refill inside the 45-day window.
- Wegovy pens through NovoCare: $199 a month for up to two fills of 0.25 mg or 0.5 mg if you’re new to the offer (through December 31, 2026). Then $349 through 2.4 mg, and $399 for 7.2 mg.
- Wegovy tablets: $149, $199 and $299 a month for 1.5 mg, 4 mg and 9 mg, and $299 for 25 mg.
NovoCare has no refill-window rule, so you no longer have to watch the LillyDirect clock. The Wegovy cost page has every way to buy.
Coverage
If you have commercial insurance, find out which brand your plan prefers and whether it wants a new prior authorization (the plan’s approval before it pays). An approval for Zepbound isn’t an approval for Wegovy. Your Lilly savings card stops with your Zepbound prescription. Novo Nordisk’s Wegovy offer brings a covered fill down to as little as $25.
On Medicare, the GLP-1 Bridge covers Wegovy as an injection or a tablet at $50 a month, while for Zepbound it covers only the KwikPen. A switch between covered drugs needs a new prior authorization from your prescriber.
What to ask
- What dose will you be prescribed, and will it be the pen or the pill?
- What date should your first Wegovy dose fall on?
- Does the use written on the prescription match what your plan covers?
- What should you do with unused Zepbound? Your pharmacist can tell you how to get rid of it.
The opposite direction is covered in Wegovy to Zepbound. The switching planner and the Wegovy guide go further.
Frequently asked questions
If I was on Zepbound 10 mg, what Wegovy dose do I take?
The labels don't say. Nothing in the Wegovy label matches a tirzepatide dose to a semaglutide dose. It gives a starting dose of 0.25 mg once weekly and a dose table that reaches the 2.4 mg maintenance dose at week 17. How your time on Zepbound affects that is your prescriber's call, and we don't publish a conversion.
Can I switch from Zepbound to the Wegovy pill instead of the pen?
Your prescriber can choose the Wegovy pill, though the label gives no steps for reaching it from Zepbound. Wegovy tablets start at 1.5 mg once daily and step up every 30 days to a 25 mg maintenance dose. You take them in the morning on an empty stomach with up to 4 ounces of water. Self-pay prices run from $149 to $299 a month.
Is Wegovy cheaper than Zepbound without insurance?
At maintenance doses, yes, on self-pay prices. Wegovy pens are $349 a month at 1 mg to 2.4 mg. Zepbound vials are $449 at 7.5 mg and above when you refill on time. If you're new to the Wegovy offer, you pay $199 for up to two fills of the two lowest doses.
Does Wegovy treat sleep apnea like Zepbound?
Wegovy isn't approved for sleep apnea. Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. Wegovy's approved uses are weight reduction, cardiovascular risk reduction and MASH. If your plan approved Zepbound for sleep apnea, a Wegovy prescription will be reviewed under a different use, so check with your plan first.
Sources (11)
- 1.FDA label (DailyMed): Wegovy prescribing information, section 1
“Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.”
- 2.FDA label (DailyMed): Zepbound prescribing information, section 1
“ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”
- 3.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 4.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm. The time of day and the injection site can be changed without the need for a dosage modification.”
- 5.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Take one WEGOVY tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces). Do not take WEGOVY tablets with other liquids besides water”
- 6.FDA label (DailyMed): Wegovy prescribing information, section 16
“Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F). If needed, prior to the pen or syringe cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days.”
- 7.
- 8.
- 9.
- 10.
- 11.
